Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Entera Bio Ltd. Director's Dealing 2022

Jan 14, 2022

35604_dirs_2022-01-14_7dbf3d53-5255-4105-bd8f-f095d86e003f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01

Reporting Person: Ratan Ramesh (U.S.based CFO)

More from Entera Bio Ltd.

Regulatory Filings 2026
May 15
Interim / Quarterly Report 2026
May 8
Regulatory Filings 2026
Mar 25
Regulatory Filings 2026
Mar 4
Director's Dealing 2026
Feb 17
Director's Dealing 2026
Feb 11
Director's Dealing 2026
Feb 11
Director's Dealing 2026
Feb 11
Director's Dealing 2026
Feb 11
Director's Dealing 2026
Feb 9
View all filings →